Last reviewed · How we verify
Amlodipine - reference
At a glance
| Generic name | Amlodipine - reference |
|---|---|
| Sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets (PHASE1)
- Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions (PHASE1)
- Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions (PHASE1)
- Amlodipine 10 mg Tablets Under Fed Conditions (PHASE1)
- Amlodipine 10 mg Tablets Under Fasting Conditions (PHASE1)
- Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets (PHASE1)
- Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions (PHASE1)
- Amlodipine Freeze-Dried Powder for Oral Solution 5 mg (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: